265 related articles for article (PubMed ID: 26340669)
1. Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells.
Shang W; Liu J; Chen R; Ning R; Xiong J; Liu W; Mao Z; Hu G; Yang J
Xenobiotica; 2016; 46(5):393-405. PubMed ID: 26340669
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1.
Xu M; Zhang L; Lin L; Qiang Z; Liu W; Yang J
J Biomed Res; 2023 Nov; 37(6):431-447. PubMed ID: 37990879
[No Abstract] [Full Text] [Related]
3. Decreased carboxylesterases expression and hydrolytic activity in type 2 diabetic mice through Akt/mTOR/HIF-1α/Stra13 pathway.
Chen R; Wang Y; Ning R; Hu J; Liu W; Xiong J; Wu L; Liu J; Hu G; Yang J
Xenobiotica; 2015; 45(9):782-93. PubMed ID: 25801056
[TBL] [Abstract][Full Text] [Related]
4. Pyrethroid insecticides: isoform-dependent hydrolysis, induction of cytochrome P450 3A4 and evidence on the involvement of the pregnane X receptor.
Yang D; Wang X; Chen YT; Deng R; Yan B
Toxicol Appl Pharmacol; 2009 May; 237(1):49-58. PubMed ID: 19249324
[TBL] [Abstract][Full Text] [Related]
5. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs.
Liu D; Gao J; Zhang C; Ren X; Liu Y; Xu Y
Pharmazie; 2011 Nov; 66(11):888-93. PubMed ID: 22204136
[TBL] [Abstract][Full Text] [Related]
6. Insulin transcriptionally down-regulates carboxylesterases through pregnane X receptor in an Akt-dependent manner.
Yang X; Zhang X; Liu Y; Xi T; Xiong J
Toxicology; 2019 Jun; 422():60-68. PubMed ID: 31005591
[TBL] [Abstract][Full Text] [Related]
7. Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells.
Takezawa T; Matsunaga T; Aikawa K; Nakamura K; Ohmori S
Drug Metab Pharmacokinet; 2012; 27(4):430-8. PubMed ID: 22333269
[TBL] [Abstract][Full Text] [Related]
8. Effect of panaxytriol on cytochrome P450 3A4 via the pregnane X receptor regulatory pathway.
Wu J; Yao N; Hu Q; Liu M; Zhang H; Xiong Y; Hu J; Xia C
Phytother Res; 2019 Apr; 33(4):968-975. PubMed ID: 30653754
[TBL] [Abstract][Full Text] [Related]
9. Activation of the aryl hydrocarbon receptor decreases rifampicin-induced CYP3A4 expression in primary human hepatocytes and HepaRG.
Rasmussen MK; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Lett; 2017 Aug; 277():1-8. PubMed ID: 28571685
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tissue-specific carboxylesterase expression by pregnane x receptor and constitutive androstane receptor.
Xu C; Wang X; Staudinger JL
Drug Metab Dispos; 2009 Jul; 37(7):1539-47. PubMed ID: 19359405
[TBL] [Abstract][Full Text] [Related]
11. Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro.
Taneja G; Chu C; Maturu P; Moorthy B; Ghose R
Drug Metab Dispos; 2018 Apr; 46(4):397-404. PubMed ID: 29440179
[TBL] [Abstract][Full Text] [Related]
12. Photochemotherapeutic agent 8-methoxypsoralen induces cytochrome P450 3A4 and carboxylesterase HCE2: evidence on an involvement of the pregnane X receptor.
Yang J; Yan B
Toxicol Sci; 2007 Jan; 95(1):13-22. PubMed ID: 17003103
[TBL] [Abstract][Full Text] [Related]
13. Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia.
Niemira M; Dastych J; Mazerska Z
Biochem Pharmacol; 2013 Jul; 86(2):231-41. PubMed ID: 23688499
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells.
Dong H; Lin W; Wu J; Chen T
BMC Biochem; 2010 Jun; 11():23. PubMed ID: 20553580
[TBL] [Abstract][Full Text] [Related]
16. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
[TBL] [Abstract][Full Text] [Related]
18. Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.
Crow JA; Bittles V; Borazjani A; Potter PM; Ross MK
Biochem Pharmacol; 2012 Nov; 84(9):1215-22. PubMed ID: 22943979
[TBL] [Abstract][Full Text] [Related]
19. Examination of the carboxylesterase phenotype in human liver.
Ross MK; Borazjani A; Wang R; Crow JA; Xie S
Arch Biochem Biophys; 2012 Jun; 522(1):44-56. PubMed ID: 22525521
[TBL] [Abstract][Full Text] [Related]
20. Arsenite and its metabolites, MMA(III) and DMA(III), modify CYP3A4, PXR and RXR alpha expression in the small intestine of CYP3A4 transgenic mice.
Medina-Díaz IM; Estrada-Muñiz E; Reyes-Hernández OD; Ramírez P; Vega L; Elizondo G
Toxicol Appl Pharmacol; 2009 Sep; 239(2):162-8. PubMed ID: 19084030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
